Related Experiment Video
Updated: Jun 26, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Poor harvest of peripheral blood stem cells in donor with thalassemia trait
Anju Radhakrishna Kurup1, Mohandoss Murugesan1, Chandran K Nair2
1Department of Transfusion Medicine, Malabar Cancer Centre, Postgraduate Institute of Oncology Science and Research, Thalassery, Kerala, India.
Here, we present a case report detailing a failed harvest from a 3-year-old child, a sibling-matched related donor for a patient with thalassemia undergoing ABO-incompatible hematopoietic stem cell transplant. The initial apheresis procedure, with the donor having an hematocrit of 29.4 and a peripheral blood CD34 count of 72 cells/µl, resulted in a poor harvest, exhibiting an inadequate collection efficiency of 21% for the apheresis procedure. We here analyzed the factors that overt red cell abnormalities (low mean corpuscular volume [MCV]) in donor may account for failures to collect the circulating CD34+ cells by standard apheresis variables despite adequate mobilization. Individuals with low MCV who are at risk of stem cells harvest failure can be identified prior to apheresis, and poor harvest can be avoided by adjustment of the apheresis variable.
Here, we present a case report detailing a failed harvest from a 3-year-old child, a sibling-matched related donor for a patient with thalassemia undergoing ABO-incompatible hematopoietic stem cell transplant. The initial apheresis procedure, with the donor having an hematocrit of 29.4 and a peripheral blood CD34 count of 72 cells/µl, resulted in a poor harvest, exhibiting an inadequate collection efficiency of 21% for the apheresis procedure. We here analyzed the factors that overt red cell abnormalities (low mean corpuscular volume [MCV]) in donor may account for failures to collect the circulating CD34+ cells by standard apheresis variables despite adequate mobilization. Individuals with low MCV who are at risk of stem cells harvest failure can be identified prior to apheresis, and poor harvest can be avoided by adjustment of the apheresis variable.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells

